Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07095608 · ClinicalTrials.gov registry record · NA
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
A NA study of Squamous Cell Carcinoma and Oral Cancer, sponsored by New York University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT07095608 is a NA study of Squamous Cell Carcinoma and Oral Cancer that is actively recruiting participants, run by New York University. The registered enrollment target is 80 participants, below the 102-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07095608, a NA study of Squamous Cell Carcinoma and Oral Cancer, is actively recruiting participants, sponsored by New York University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective study involving human participants. Pressure and stretch sensitivity measures between oral cancer patients and healthy subjects will be compared. Pain stimulation will be conducted on the site of the cancer in 40 oral cancer patients, and on the tongue in 40 healthy volunteers, using pressure and stretch sensitivity tests.
Conditions Studied
Interventions
- BEHAVIORAL Pressure and stretch sensitivity testing
Study Locations (1)
New York
- NYU College of Dentistry - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2029-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07095608
The ClinicalTrials.gov registry entry for NCT07095608 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 102-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (22% lower). The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Squamous Cell Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Pressure and stretch sensitivity testing is the first listed.
NCT07095608 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07095608 about?
NCT07095608 is a clinical study titled "Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain". This is a prospective study involving human participants. Pressure and stretch sensitivity measures between oral cancer patients and healthy subjects will be compared. Pain stimulation will be conducted on the site of the cancer in 40 oral cancer patients, and on the tongue in 40 healthy volunteers,...
What is the current status of trial NCT07095608?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-09-01. Estimated completion is 2029-12-30.
What conditions does trial NCT07095608 study?
This clinical trial studies the following conditions: Squamous Cell Carcinoma, Oral Cancer.
What interventions are being tested in trial NCT07095608?
The interventions under investigation include: Pressure and stretch sensitivity testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT07095608?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07095608 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Squamous Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
RECRUITING · NA
-
TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck
ACTIVE NOT RECRUITING · NA
-
Comparing Two Surveillance Approaches for People Who Have Received Treatment for HPV-associated Head and Neck Cancer and Show No Signs of Disease
ACTIVE NOT RECRUITING · NA
-
Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery
COMPLETED · NA
-
Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and Larynx
COMPLETED · NA
-
Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.